Contingency Management for Smoking Cessation in the Homeless



Status:Completed
Conditions:Smoking Cessation
Therapuetic Areas:Pulmonary / Respiratory Diseases
Healthy:No
Age Range:18 - Any
Updated:1/17/2018
Start Date:October 2012
End Date:July 2016

Use our guide to learn which trials are right for you!

Smoking cessation services are an unmet need among the homeless, who smoke at rates more than
3 times the national estimate; successful interventions in this underserved population have
the potential for improving individual and public health. Contingency management (CM) is a
behavioral intervention with efficacy in a number of substance use disorder populations,
including smokers. However, no known studies have evaluated the effect of CM in homeless
smokers. The investigators plan to examine smoking-related outcomes in homeless
treatment-seeking smokers (N = 70) randomized to standard care smoking cessation (transdermal
nicotine replacement therapy [NRT] + standard counseling + carbon monoxide [CO] monitoring)
or standard care plus CM (NRT + standard counseling + CO monitoring + CM) conditions.
Standard counseling and CO monitoring will occur for the first 4 weeks, with NRT use
continuing through week 8. Participants in both conditions will meet with study staff up to
twice daily on weekdays for biochemical verification of smoking status. Participants in the
CM condition will have the opportunity to earn prizes for negative breath samples (CO ≤ 4
ppm) up to twice daily on weekdays. CO breath samples will be collected at all visits. The
investigators expect that participants randomized to CM will have better outcomes compared to
those in standard care.


Inclusion Criteria:

- age ≥ 18 years

- homeless

- regular smoker

Exclusion Criteria:

- non-English speaking

- contra-indications for transdermal nicotine

- in recovery for pathological gambling
We found this trial at
1
site
New Britain, Connecticut 06051
Principal Investigator: Carla Rash, Ph.D.
?
mi
from
New Britain, CT
Click here to add this to my saved trials